Genomes front and centre of rare disease diagnosis
24 June 2020Cambridge-led study discovers new genetic causes of rare diseases, potentially leading to improved diagnosis and better patient care.
A BLUEPRINT for blood cells: Cambridge researchers play leading role in major release of epigenetic studies
17 November 2016Cambridge researchers have played a leading role in several studies released today looking at how variation in and potentially heritable changes to our DNA, known as epigenetic modifications, affect blood and immune cells, and how this can lead to disease.
